4496-30-4Relevant academic research and scientific papers
Synthesis and biological evaluation of naphthoquinone phenacylimidazolium derivatives
Yuan, Jing,Liu, Zhanxiong,Zhang, Zhenfeng,Yan, Deyue,Zhang, Wanbin
supporting information, (2021/04/05)
In order to expand structural diversity and improve antitumor efficiency, forty new naphthoquinone phenacylimidazolium derivatives were designed, synthesized and evaluated. Good synthetic yields were obtained under mild conditions using easily available starting materials. Cytotoxicity of these compounds was evaluated in vitro against a panel of human tumor cell lines: human breast carcinoma cell lines (MCF-7), human cervical carcinoma cell lines (HeLa), and human lung carcinoma cell lines (A549). Among them, the optimal compound 7m showed splendid antiproliferative activity with low to 50 nM IC50 values against MCF-7 and excellent selectivity of 256-fold compared with the normal cell lines L929. Compound 7m induced apoptosis in a dose-dependent manner. Further mechanism experiments showed that compound 7m dramatically inhibited the expression of survivin and activated the pro-apoptotic protein caspase-3. Our results indicated that the structural modification on the 1,3-substituents of naphthoquinone imidazoliums without 2-substituent is also promising to obtain new antitumor compounds.
Use of naphthoquinone derivative as inhibitor for IDO1 and/or TDO
-
Paragraph 0199-0202, (2020/01/31)
The invention discloses a use of a naphthoquinone derivative as an inhibitor for IDO1 and/or TDO. The derivative is shown as a general formula (I), and the definition of each substituent is detailed in the specification. The compound represented by the general formula (I) has an inhibitory effect on indoleamine-2,3-dioxygenase 1 (IDO1) and/or tryptophan-2,3-dioxygenase (TDO), and can be used for treating diseases with IDO1- and/or TDO-mediated tryptophan metabolism as pathological features, including but not limited to tumors, autoimmune diseases, infectious diseases, Alzheimer's disease, depression, and anxiety disorder.
Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors
Pan, Liangkun,Zheng, Qiang,Chen, Yu,Yang, Rui,Yang, Yanyan,Li, Zhongjun,Meng, Xiangbao
, p. 423 - 436 (2018/08/17)
Indoleamine 2,3-dioxygenase 1 (IDO1) mediated kynurenine pathway of tryptophan degradation is identified as an appealing and novel target in immunotherapy for the treatment of cancer. In this study, a novel series of naphthoquinone derivatives were synthesized, characterized and evaluated for their inhibitory activities against IDO1, and their structure?activity relationship was investigated. Among them, compounds T16, T44, T47, T49, T53 and T54 displayed potent IDO1 inhibitory activities with IC50 values ranging between 18 and 61 nM, which are more potent than INCB024360 undergoing clinical trial III evaluation. In addition, compounds T28, T44 and T53 decreased the kynurenine levels in rat plasma by 30%–50%. Compounds exhibiting excellent IDO1 inhibitory activities were also evaluated for their inhibitory activities against tryptophan 2,3-dioxygenase (TDO). Of which, compound T28 (IDO1 IC50 = 120 nM) showed promising TDO inhibition (IC50 72 nM) and was identified as an IDO1/TDO dual inhibitor.
Long-Life, High-Rate Lithium-Organic Batteries Based on Naphthoquinone Derivatives
Lee, Joungphil,Kim, Hoon,Park, Moon Jeong
, p. 2408 - 2416 (2016/05/09)
We report the facile synthesis of new naphthoquinone (NQ) derivatives for use in lithium-organic batteries to improve performance. The rational design of these NQ derivatives is based on theoretical calculations. Our lithium-organic batteries demonstrate remarkable charge-discharge properties, for example, a high discharge capacity of 250 mAh g-1 (363 mAh cm-3), discharge potential plateaus in the range of 2.3-2.5 V, and 99% capacity retention after 500 cycles at 0.2C. In particular, the batteries had excellent rate performance up to 50C with reversible redox behavior, unlike most other organic cathode materials. The key to success was a simple molecular substitution, addition of amino groups at the 2- and 3- positions of the NQ ring, yielding 2,3-diamino-1,4-naphthoquinone (DANQ). DANQ has an exceptionally low band gap of 2.7 eV and greater than 20-fold enhancement in the lithium diffusion rate compared to unmodified NQ. The fundamental shortcoming of the organic molecules, i.e., their solubility in the electrolyte, was resolved by covalent linking of the amino groups to the surfaces of the cathode framework. The cyclization of amino groups in DANQ yielded 1H-naphtho[2,3-d]imidazole-4,9-dione (IMNQ), enabled us to achieve a 0.15 V enhancement in the redox potential owing to the delocalized electron distribution in the heteroaromatic ring. Our work suggests that NQ derivatives with modulated charge/ion transport properties are a viable alternative to the more widely studied lithium metal oxides.
